S02711 Summary:

BILL NOS02711A
 
SAME ASSAME AS A05214-A
 
SPONSORYOUNG
 
COSPNSRAVELLA, BALL, BRESLIN, DIAZ, ESPAILLAT, GOLDEN, GRISANTI, LANZA, LATIMER, MARCHIONE, MARTINS, PARKER, PERKINS, RANZENHOFER, ROBACH, SAVINO, SQUADRON, TKACZYK, VALESKY
 
MLTSPNSR
 
Add Art 33 SS3301 & 3302, Ins L
 
Regulates step therapy and first fail health insurance policies and contracts.
Go to top    

S02711 Actions:

BILL NOS02711A
 
01/23/2013REFERRED TO INSURANCE
01/08/2014REFERRED TO INSURANCE
02/14/2014AMEND AND RECOMMIT TO INSURANCE
02/14/2014PRINT NUMBER 2711A
Go to top

S02711 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S02711 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         2711--A
 
                               2013-2014 Regular Sessions
 
                    IN SENATE
 
                                    January 23, 2013
                                       ___________
 
        Introduced  by  Sens.  YOUNG,  BALL,  BRESLIN,  GOLDEN, GRISANTI, LANZA,
          MARCHIONE, PARKER, TKACZYK, VALESKY -- read twice and ordered printed,
          and when printed to be committed to  the  Committee  on  Insurance  --
          recommitted  to  the  Committee on Insurance in accordance with Senate
          Rule  6,  sec.  8  --  committee  discharged,  bill  amended,  ordered

          reprinted as amended and recommitted to said committee
 
        AN ACT to amend the insurance law, in relation to the regulation of step
          therapy and first fail policies
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The insurance law is amended by adding a new article 33  to
     2  read as follows:
     3                                 ARTICLE 33
     4                       REGULATION OF STEP THERAPY AND
     5                             FIRST FAIL POLICIES
     6  Section 3301. Definitions.
     7          3302. Prescription drug restriction overrides.
     8    § 3301. Definitions. As used in this article:
     9    (a)  "Insurer"  shall mean any person or entity who offers a policy of

    10  accident and/or health insurance pursuant to section three thousand  two
    11  hundred sixteen, three thousand two hundred twenty-one, or four thousand
    12  three  hundred three of this chapter or article forty-four of the public
    13  health law.
    14    (b) "Pharmacy benefit management" or  "PBM"  shall  mean  the  service
    15  provided  to  an  insurer, directly or through another entity; including
    16  the procurement  of  prescription  drugs  to  be  dispensed  to  covered
    17  persons,  or the administration or management of prescription drug bene-
    18  fits including, but not limited to, any of the following:
    19    (1) a mail order pharmacy;
    20    (2) claims processing, retail network management and payment of claims
    21  to pharmacies for dispensing prescription drugs;
 

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD05355-03-4

        S. 2711--A                          2
 
     1    (3) clinical or other formulary, or preferred drug list development or
     2  management;
     3    (4)  negotiation  or  administration  of  rebates,  discounts, payment
     4  differentials or  other  incentives  for  the  inclusion  of  particular
     5  prescription  drugs  in a particular category or to promote the purchase
     6  of particular prescription drugs;
     7    (5) patient compliance, therapeutic intervention and  generic  substi-
     8  tution programs; and
     9    (6) disease management.

    10    §  3302. Prescription drug restriction overrides. (a) When medications
    11  for the treatment of any medical condition are restricted for use by  an
    12  insurer  or  PBM  by a step therapy or fail first protocol, a prescriber
    13  shall have access to a clear and convenient process at no charge to such
    14  prescriber and/or patient to override such restrictions from the insurer
    15  and may expeditiously override such restriction if:
    16    (1) such prescriber, in his or  her  professional  judgment,  believes
    17  that the preferred treatment by the insurer or the PBM has been ineffec-
    18  tive  in the treatment of the covered person's disease or medical condi-
    19  tion; or
    20    (2) based on  sound  clinical  evidence  and  medical  and  scientific
    21  evidence:

    22    (A)  such  prescriber,  in  his or her professional judgment, believes
    23  that the preferred treatment is expected to be ineffective based on  the
    24  known  relevant physical or mental characteristics of the covered person
    25  and known characteristics of the drug regimen, and is likely to be inef-
    26  fective or adversely affect the drug's effectiveness or patient  compli-
    27  ance; or
    28    (B)  such  prescriber,  in  his or her professional judgment, believes
    29  that the preferred treatment has caused or is likely to cause an adverse
    30  reaction or other harm to the covered person.
    31    (b) The duration of any step therapy or fail first protocol shall  not
    32  be longer than either (1) the period deemed necessary by the prescribing

    33  physician or health care professional to determine the treatment's clin-
    34  ical effectiveness, or (2) a period of thirty days.
    35    (c)  Nothing  in this section shall require coverage for an additional
    36  condition not already covered by the policy or contract, or which is not
    37  otherwise covered by law.
    38    § 2. This act shall take effect on the one hundred twentieth day after
    39  it shall have become a law.
Go to top